• Breast tumor
  • Adalimumab Concentration and Anti-Adalimumab Antibody
  • Tumor Necrosis Factor Alpha (TNF-α)
  • Nudix Hydrolase 15 (NUDT15) Gene Mutation Analysis
  • Triglycerides, Serum
  • 5-AMP-Activated Protein Kinase, Gamma-2 Subunit (PRKAG2) Mutation Analysis
  • Hemoglobin, Free, Plasma
  • Hereditary Hemolytic Anemia Gene Mutation Panel, NGS
  • Actinomyces, Molecular Method
  • Lymphocytic choriomeningitis (LCM)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /KRAS Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

KRAS Gene Mutation Analysis
Medical Test

ICD10
Access to KRAS Gene Mutation Analysis is restricted.